Member Info for MrIndia

Then any news on the long list of outstanding news items expected in the next 3 months will surely cause a massive rerate?

not a ramp but just an obsevervation ....

Thanks for the advise and agree. I have been following Hemo now for 2 years and very positive about it. I hope there is no delay but Vlad's tweet, the recent presentation on Hemo, Lunus 1 opinion and the number of people on here that also are fully vested gives me hope but of course understand there are no guarantees.

I am well down on Genedrive because people's expectations on immediate sales were unfounded and people sold out and it caused a massive downtrend ... nevertheless the company and products are solid and so it will rerate. All these pharma stocks are definately not for the feint hearted

Really hope this news comes soon .... believing in your words Lunus 1 !!!!

yes but stupid people are listening to BS and selling !!!!

I am a total believer and i know it has been battered for people's wrong expectations from the RNS timeframe. I have a high average and am here for the long term but just trying to judge when is the best time to buy. I think it is already far too much oversold and it will bounce but someone larger buyers are keeping it down to get a better buy in price ...

Hi All

The share price is in freefall which is a little worrying. I thought someone stated on Friday that the L2 data was positive and we would expect a turnaround ... anyone have a view and where the bottom of this implosion is?

FEELS MUCH WORSE ... and don't know where the bottom is

- 6 weeks ago this was 140p and 2 weeks ago was around 120p and hovering around 110p before the RNS
- The shares had gone up on the back of possible sales results or contracts. They didnt come in time and so people sold. The market is still the same, the opportunity is still the same
- So people (sorry AIM) have lost confidence in short term sales even though the BC contract was recently signed.
- The price previously wasnt even valueing the opps with US DOD and Ear market in the UK and beyond I suspect
- I invested in Omega and Avacta and so them go down to 40p for omega and 90p in Avacta. This was because Vaccines were announced but look at their share price now.
- Only negative i see people's high expectations vrs a poor sales group in GDR (that may be resolved now with Mountain group and Beckman) and results will be seen soon

Conclusion : This is now a 3 - 6 month share. This will result in sales and contracts or not. Regulatory will be under to approve if these are solid products. I think this is a great price to buy in but unfortunately AIM shares are driven by sentiment and not fundementals.

It wont be sold at that price in India ... and even if it is there are many corporates / mid market people who are currently paying over $100 for private tests in India.

I operate in india and this is common ... regulatory is a nightmare and can take lots of time but once opened can be explosive.

Listening to budd i am even more positive ... the share price was hit because of no sales yet but this is a timing thing. I think Covid product will sell soon and also i am excited to hear about the Thailand approval (so it has been accepted elsewhere) and also the other US DOD and UK hearing opps. I am going to buy more ...

If u an update?

https://www.proactiveinvestors.co.uk/companies/news/944876/genedrive-optimistic-about-second-half-of-financial-year-as-it-eyes-revenue-potential-from-existing-contracts-944876.html

If what he says is real, then this is actually a really solid hold for the future and to buy in some more now. This rocketed from 80 pence to 140 pence on BC partnership. Their strategy shifted to high value clients and so will take time ... If just one of these contracts are confirmed with revenue / sales, this will move fast but there is always risk vrs return.

David Budd, CEO of genedrive plc, commented:

During 2020 the Company’s development focus moved to the global COVID PCR testing opportunity. While commercial progress has been slowed by registration requirements, the Company made great strides in the development of our COVID test portfolio, POC test platform development, scalable manufacturing capability, and a commercial distribution arrangement with Beckman Coulter that has the potential to be significant and lang-term. Much of our focus has shifted away from low and middle income markets to more western markets with DoD, AIHL, and COVID, driven by the market dynamics and restrictions of travel. These markets however work under standard commercial terms and cycles, and offer more predictable, and often higher margin commercial opportunities, and we anticipate this focus will remain for the foreseeable future.”

Yes it will but will take some time ... this has gone down too much since the whole markets are down today and so probably oversold by 10 - 15%. This went up nearly 50% on the back of just the BC announcement so with some sales and revenue projections it could easily recover. Nevertheless it will take time to get confidence back and will need good RNSs in future with clear timelines and not twitter updates by random people !!!

Do we expect any more news and details on the future in tomorrows meetings?

if so, isn't this a great price to top up now?

Really hope that this positive update comes within next 10 days .... seeing red every day is a little demoralising

The results were not what we wanted but if no approvals, no approvals. If they had come in time, it would be great but didn't. I cannot believe a company like BC would partner with GDR unless they had forward visibility or could influence approvals / revenue opps. Sadly it looks like many were expecting too much as i said many times (like Omega, Hemo, Deepverge) and other pharma stock and because they didn't get what they wanted they sold out.

Yes I would have liked a more clear and positive result but this company has a pipeline of products and given time it will be able to deliver ... there is no way that BC will sit on the sidelines and let their partnership go to waste.

I hope we get more clarity tomorrow ...

and its just started ... not the feint hearted this day

Very strange and worrying? Does anyone know why?

Sadly people expecting an RNS every day this week and nervousness will keep selling this week ... I dont think anything major will be announced this week and people wont be happy ... even though the company is travelling in the right direction.